MassRoots Comments on White House Press Secretary Sean Spicer's Cannabis Policy Remarks

DENVER, Feb. 24, 2017

"This is the first time a sitting Republican President has acknowledged the medical benefits of cannabis while we expect Congress to extend the Rohrabacher-Farr amendment prohibiting the Department of Justice from interfering with state medical cannabis programs," stated MassRoots CEO Mr. Isaac Dietrich. "While it is disheartening to hear the White House not endorse recreational cannabis, these remarks play to President Trump's base while subtly giving the green light to medical cannabis. We do not believe the Trump Administration will take significant action to shut down the recreational cannabis industry in states like Colorado, where the cannabis industry employs tens of thousands of people and contributes more than $100 million in taxes annually, mainly towards state education systems."

MassRoots believes that if President Trump met with medical cannabis CEOs, he would be impressed with the vast amount of jobs and economic growth the cannabis industry can create.

About MassRoots

MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company's mobile apps enable consumers to make medical cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements

Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots' business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.